Helping Texans access the benefits of medical cannabis is an important goal for Surterra Texas, one of the state’s vertically integrated medical cannabis licensees, and the company has made strides lately with its efforts to bring telehealth services and cannabis-infused lozenges to the state’s patient base.
Texas’ massive size, as well as its requirement that doctors in the medical cannabis program be board-certified specialists, make it challenging for patients to find and visit a physician who can prescribe medical cannabis, according to Surterra Texas President Marcus Ruark.
This led the company to partner with Heally to bring telehealth services to patients across the state to help them see a doctor and potentially get a prescription for medical cannabis from the comfort of their own homes.
“Obviously, that’s very helpful in a large state like Texas, but it’s also helpful in these COVID times,” Ruark tells Cannabis Business Times and Cannabis Dispensary. “Anything we can do to make things easier for patients is a win for Texas.”
The telehealth services have been well-received by both patients and doctors, he adds, and the Texas Department of Public Safety (DPS), which regulates the state’s medical cannabis program, has been very supportive of telemedicine.
Photos courtesy of Parallel
Surterra Texas’ lozenges, part of the company’s Relief product line, feature a 1:9 ratio of CBD to THC and are one of the first non-tincture products in the state.
Surterra Texas’ efforts to expand patient access don’t stop there—the company recently launched a new product line of cannabis-infused lozenges, the first non-tincture form of medical cannabis in the state.
The lozenges, part of Surterra’s Relief product line, also represent the company’s first THC-dominant medical cannabis products, Ruark adds, featuring a 1:9 ratio of CBD to THC.
The typical concentrations of tinctures in the state have been